-------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: October 4, 2004
Date of Earliest Event Reported: October 4, 2004
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware 1-12091 22-3436215
(State or other jurisdiction of (I.R.S. Employer Identification
incorporation or organization) (Commission File Number) Number)
20 Wight Avenue, Suite 100
Hunt Valley, Maryland 21030
(Address of principal executive offices)
Registrant's telephone number, including area code: (410) 229-4400
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[X] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On October 4, 2004, Millennium Chemicals Inc. and Lyondell
Chemical Company announced the expected closing date for their proposed business
combination transaction. Lyondell and Millennium have set November 30, 2004 as
the date for their respective shareholder meetings to consider the proposed
transaction, and assuming shareholder approval, the transaction is expected to
close on December 1, 2004. Millennium and Lyondell's October 4, 2004 press
release regarding the expected December 1, 2004 closing date is being furnished
with this Current Report on Form 8-K as Exhibit 99.1. The foregoing press
release shall not be deemed to be "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934 or otherwise subject to the liabilities of that
Section.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
Exhibit Description
99.1 Press Release issued October 4, 2004
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on behalf of the undersigned
hereunto duly authorized.
Dated: October 4, 2004 MILLENNIUM CHEMICALS INC.
By: /s/ C. William Carmean
-----------------------------------------
C. William Carmean
Senior Vice President, General Counsel &
Secretary
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Press release issued October 4, 2004
STATEMENT OF DIFFERENCES
Characters normally expressed as subscript shall be preceded by........ [u]